BiotechTube
Home/T3 Pharmaceuticals/Daniel Weber
DW

Daniel Weber

Chairman of the Board

T3 Pharmaceuticals

Therapeutic Areas

Oncology

T3 Pharmaceuticals Pipeline

DrugIndicationPhase
T3P-Y058-1Solid TumorsPre-clinical

Leadership Team at T3 Pharmaceuticals

DS
Dr. Simon J. Ittig
Chief Executive Officer
DC
Dr. Christoph A. Kasper
Chief Scientific Officer
PD
Prof. Dr. med. Gerd Munzert
Chief Medical Officer
View full T3 Pharmaceuticals profile